The variant set analysis using SMMAT (Chen et al., 2019) and leveraging the SKAT-O framework (Lee et al., 2012), suggests that the accumulation of rare ARRB1 variants is associated with HDRS score changes and remission rates over the course of ATD treatment, as the burden test results were significant. The gene discussed is ARRB1; the disease is Jeune syndrome.